On this page
Oculocutaneous albinism type 1
OCA1 is caused by changes in the TYR gene, which affects melanin production. Individuals with OCA1 typically have very fair skin, white or light-coloured hair, and lifelong visual challenges, often from birth.
Available at Jeen Health
Clinical tests that include this
Overview
Oculocutaneous albinism type 1 (OCA1) is a rare inherited condition that affects the production of melanin, the natural pigment responsible for the colour of skin, hair, and eyes. There are two main subtypes of OCA1: OCA1A, where no melanin is produced at all, and OCA1B, where a small amount of melanin may be produced over time [PMID:20301479]. This condition is present from birth and affects individuals globally, with an estimated prevalence of about 1 in 40,000 people.
Because melanin also plays a role in the normal development of the eyes, individuals with OCA1 experience a range of visual impairments in addition to changes in their skin and hair colour. These visual issues are a key feature of the condition and can vary in severity. Managing OCA1 often involves protecting the skin and eyes from sun exposure and providing support for visual challenges.
Symptoms & clinical features
The primary symptoms of OCA1 involve a distinctive lack of pigment. In OCA1A, individuals are born with very white skin, white hair, and light blue or translucent irises that may appear pinkish-red due to the visible blood vessels in the back of the eye. This complete lack of pigment typically remains throughout life [PMID:20301479].
For those with OCA1B, pigment may be absent at birth but can develop slowly over time, leading to slightly darker hair (e.g., yellow, cream, or light brown) and some tanning ability in the skin. Eye colour might also darken slightly. Despite these differences, both subtypes experience eye-related symptoms, including reduced sharpness of vision (visual acuity), rapid involuntary eye movements (nystagmus), sensitivity to light (photophobia), and misrouting of nerve fibres from the eyes to the brain, which can affect depth perception.
Other visual features commonly associated with OCA1 include strabismus (misalignment of the eyes) and hypoplasia of the fovea, which is an underdeveloped central part of the retina critical for sharp, detailed vision.
Video: Genetics 101
Affected organs
OCA1 primarily affects organs and tissues responsible for pigmentation and vision. The skin, hair follicles, and eyes are most prominently involved due to the absence or reduction of melanin. Specifically, the melanocytes (pigment-producing cells) in these areas are unable to produce adequate melanin.
Within the eyes, the iris, retina, and optic nerves are particularly impacted. The lack of pigment in the iris causes light to scatter within the eye, leading to photophobia. The absence of melanin in the retina affects its normal development and function, contributing to reduced visual acuity and foveal hypoplasia. The abnormal crossing of optic nerve fibres also results from the lack of pigment during early eye development.
Risks & severity
The severity of OCA1 largely depends on whether any melanin can be produced. OCA1A, with its complete absence of melanin, represents the more severe end of the spectrum in terms of pigmentation. Individuals with OCA1A have a very high lifetime risk of sun damage, including severe sunburn, and an increased risk of developing skin cancers, such as basal cell carcinoma, squamous cell carcinoma, and melanoma, if not adequately protected from the sun [PMID:33659459].
OCA1B individuals may have slightly less severe pigmentary features and a potentially lower, but still elevated, risk of sun damage and skin cancer compared to the general population. Visual impairment is a lifelong characteristic for all individuals with OCA1, often ranging from moderate to severe, and is generally stable after early childhood. The age of onset for symptoms is at birth, as the condition is congenital.
Genetic causes
Oculocutaneous albinism type 1 is caused by genetic changes (variants) in the TYR gene. This gene provides instructions for making an enzyme called tyrosinase. Tyrosinase is essential for the first step in the biochemical pathway that produces melanin pigments, both eumelanin (brown/black pigment) and pheomelanin (red/yellow pigment) [PMID:20301479].
In individuals with OCA1A, the variants in TYR typically lead to a complete loss of tyrosinase enzyme activity, meaning no melanin can be produced. In OCA1B, the TYR gene variants result in an enzyme that has reduced activity or is temperature-sensitive, meaning it works less efficiently or only at lower temperatures. This allows for some limited melanin production, which may increase with age or in cooler body areas. Understanding the specific variant in the TYR gene can help predict whether an individual will have OCA1A or OCA1B features.
- TYR tyrosinase
Inheritance pattern
OCA1 is inherited in an autosomal recessive pattern. This means that a person must inherit two altered copies of the TYR gene - one from each parent - to develop the condition. Individuals who inherit only one altered copy of the TYR gene are called carriers. Carriers typically do not show any symptoms of OCA1 because their one working copy of the gene is sufficient to produce enough tyrosinase enzyme.
When both parents are carriers of a TYR gene variant, there is a 25% chance with each pregnancy that their child will inherit two altered copies and be affected by OCA1. There is a 50% chance the child will be a carrier like their parents, and a 25% chance the child will inherit two working copies of the gene and not be affected or be a carrier.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
Diagnosis & testing
A diagnosis of OCA1 is typically made based on characteristic clinical features observed at birth or in early infancy, including very fair skin, light hair, and specific eye signs such as nystagmus and photophobia. An ophthalmologist may identify features like foveal hypoplasia and iris translucency during an eye examination.
Genetic testing is used to confirm the diagnosis and distinguish OCA1 from other types of albinism. This involves analysing the TYR gene to identify specific pathogenic variants. Such testing is often requested by a clinical geneticist or an ophthalmologist. In the UK, genetic testing for inherited eye disorders, which can include albinism, falls under the NHS Genomic Medicine Service and may be accessed via specific R-codes.
Management & lifestyle
Management of OCA1 focuses on protecting the skin and eyes and optimising vision. Due to extreme sun sensitivity, lifelong rigorous sun protection is crucial. This includes wearing protective clothing, wide-brimmed hats, sunglasses with UV protection, and broad-spectrum sunscreen with a high SPF, even on cloudy days. Regular skin checks by a dermatologist are recommended to monitor for early signs of skin cancer.
For ocular symptoms, management includes regular eye examinations with an ophthalmologist. Corrective lenses (glasses or contact lenses) can help improve vision, though they may not correct it to a typical range. Special tinted lenses or prescription sunglasses can reduce photophobia. Low vision aids, such as magnifiers and large-print materials, can also be beneficial. Referral to vision support services and educational support tailored to visual impairment are often helpful. There are no treatments that can restore melanin production.
UK care pathway
In the UK, individuals suspected of having OCA1 would typically be referred to a clinical genetics service or an ophthalmology department. Genetic counselling is an integral part of this pathway, providing information about the condition, inheritance patterns, and reproductive options. Genetic testing for albinism is available through the NHS Genomic Medicine Service. The specific genetic test for conditions like OCA1 would fall under relevant R-codes for inherited ophthalmological or dermatological conditions. Genetic counsellors help families understand test results and their implications.
Frequently asked questions
Can someone with OCA1 ever develop a tan?
Individuals with OCA1A, who produce no melanin, cannot tan and will always burn easily. Those with OCA1B may develop some minimal pigment over time and might experience a very slight tan, but they remain highly susceptible to sunburn and require strict sun protection.
Is OCA1 contagious?
No, oculocutaneous albinism type 1 is a genetic condition caused by changes in a person's genes. It cannot be passed from person to person through contact or any other non-genetic means.
Will people with OCA1 go blind?
Individuals with OCA1 experience lifelong visual impairment, but they do not typically go completely blind. Their vision is usually stable after early childhood, and while it may be significantly reduced, they generally retain some functional vision. Various aids and strategies can help manage visual challenges.
What is the life expectancy for someone with OCA1?
OCA1 itself does not directly affect life expectancy. Individuals with OCA1 generally have a normal lifespan. However, careful management of sun exposure is crucial to prevent skin damage and reduce the increased risk of skin cancers, which if left untreated, could impact health.
Are there any treatments to increase pigment production for OCA1?
Currently, there are no medical treatments available that can increase melanin production in individuals with OCA1. Management focuses on protecting skin and eyes from sun damage and providing support for visual impairment.
References
- Schlessinger DI, Rahimi N, Schlessinger J. Biochemistry, Melanin. 2025. PMID: 29083759
- Oh D, Seok C, Park HW. Generation and ophthalmological characterization of oculocutaneous albinism type 1 pig models by selection-free genome editing. Scientific reports. 2025. PMID: 41444327
- Dolinska MB, Kus NJ, Farney SK. Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity. Pigment cell & melanoma research. 2017. PMID: 27775880
- Oetting WS, Fryer JP, Shriram S. Oculocutaneous albinism type 1: the last 100 years. Pigment cell research. 2003. PMID: 12753405
- Diallo M, Sylla O, Sidibé MK. Genotypic spectrum of albinism in Mali. Pigment cell & melanoma research. 2024. PMID: 38720644
- Adam MP, Bick S, Mirzaa GM. Oculocutaneous Albinism Type 1 – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY. 1993. PMID: 20301345
- Oetting WS. The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): A model for understanding the molecular biology of melanin formation. Pigment cell research. 2000. PMID: 11041207
- Seruggia D, Josa S, Fernández A. The structure and function of the mouse tyrosinase locus. Pigment cell & melanoma research. 2021. PMID: 33098271